论文部分内容阅读
肝素治疗脑血管病已有40余年的历史,是治疗急性缺血性中风的常用药物,但对它的评价却一直没有定论,肯定和否定意见都有,是当今神经病学家争论的最热门的课题之一。为了确切地评价肝素的疗效,本文作者随机选择了美国神经病学会所属的349名神经病学家作为调查对象。调查内容涉及11个问题,主要包括以往处理急性局灶性缺血性中风患者肝素的使用情况及疗效评价。结果表明,大多数的神经病学家都常用肝素治疗某些急性缺血性中风,尽管使用的剂量和方法不完全一致。最常见的
Heparin has been used in the treatment of cerebrovascular disease for more than 40 years and is a commonly used drug for the treatment of acute ischemic stroke. However, its evaluation has been inconclusive, affirmative and negative, and is arguably the hottest issue among neurologists today One of the topics. In order to accurately assess the efficacy of heparin, the authors randomly selected 349 neurologists affiliated with the American College of Neurology as subjects. The survey covered 11 issues, including the use of heparin in the treatment of acute focal ischemic stroke in the past and the evaluation of the therapeutic effect. The results show that most neurologists use heparin to treat certain acute ischemic stroke, although the dosages and methods used are not exactly the same. most common